All Posts By

Smartkarma Daily Briefs

Daily Brief Crypto: Crypto Moves #40 – Another ‘DeFi Summer’ Is On the Horizon and more

By | Crypto, Daily Briefs

In today’s briefing:

  • Crypto Moves #40 – Another ‘DeFi Summer’ Is On the Horizon


Crypto Moves #40 – Another ‘DeFi Summer’ Is On the Horizon

By Mads Eberhardt

  • The summer of 2020 marked a pivotal moment for decentralized finance (DeFi), as it gained significant momentum, reflected by the surge in Total Value Locked (TVL) across DeFi protocols.
  • Chart 1: Total Value Locked (TVL) in 2019 and 2020While DeFi continued to grow through 2021, it was the rapid expansion during the summer of 2020 that left a lasting impression on the community, earning the period the moniker ‘DeFi Summer.’Chart 2: Total Value Locked (TVL), All TimeAlthough the actual season may be shifting towards winter, ‘DeFi Summer’ is making a comeback, but the Total Value Locked is still quite far from its 2021 peak.
  • However, it is likely only a matter of time before we surpass that all-time high – potentially as soon as the first half of 2025.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Macro: Macro/Rates Watch: When the entire foundation rests on liquidity and more

By | Daily Briefs, Macro

In today’s briefing:

  • Macro/Rates Watch: When the entire foundation rests on liquidity
  • Walker’s Weekly: Dr. Jim’s Summary of Key Global Macro Developments – 23 Aug 2024
  • Heard From Fortress Hill: Weekly Market Observations (23 Aug 2024)
  • HEW: Pushback to Inconsistent Pricing


Macro/Rates Watch: When the entire foundation rests on liquidity

By Andreas Steno

  • What a July we’ve had.
  • The G3 central banks have now received plenty of labor market data that justifies cutting rates fairly aggressively.
  • In our opinion, this is a tricky trend to resist, even if market pricing does admittedly seem aggressive.

Walker’s Weekly: Dr. Jim’s Summary of Key Global Macro Developments – 23 Aug 2024

By Dr. Jim Walker

  • The U.S. released revised non-farm payroll figures, with significant job cuts expected, but the fiscal deficit continues to grow, raising concerns about economic stability.
  • Frequent data revisions and premature releases, such as those in Japan and India, highlight the need for more accurate and delayed economic data reporting.
  • Political unrest in Indonesia as the government attempts to overturn a court ruling to allow President Jokowi’s son to run for governorship, reflecting a trend towards autocracy in the region.

Heard From Fortress Hill: Weekly Market Observations (23 Aug 2024)

By Alex Ng

  • Hang Seng barely moves this week, as we predicted. Hang Seng is likely to go sideway from 16000 to 18000 levels for the rest of the years.
  • S&P500 likely wise moves little, up by 0.73% for the week. US equity market will likely has no clear direction before the Sep rate cut.
  • Gold retrieves little by less than 0.5% against a half year uprising trend that has accumulated to 23.6% up from half year ago.

HEW: Pushback to Inconsistent Pricing

By Phil Rush

  • Resilient activity data does not align with tight policy rates, suggesting deep cuts may not be necessary. Despite the resilience and loosening conditions enjoyed by equities, they should not occur simultaneously. The proximity of equities and GBP to their peaks creates an unattractive asymmetry.
  • Next week, stretched market pricing may overshadow other factors due to a sparse data calendar and widespread late summer holidays.
  • The main event to look out for is the Flash EA inflation for August, with forecasts indicating a potential renewed slowdown in headline figures, aligning closely with the consensus.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Australia: Whitehaven Coal and more

By | Australia, Daily Briefs

In today’s briefing:

  • Whitehaven Nail the Landing, Patriot look to the Future


Whitehaven Nail the Landing, Patriot look to the Future

By Money of Mine

  • Blackwater sell down to Nippon and Jfezenhe Steel for US 1.08 billion upfront
  • Deal includes selling 30% of Blackwater, reducing net debt by 150 million and potential future contingent payments
  • Transaction costs and transition costs higher than expected, but deal significantly impacts balance sheet and future cash flow

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief South Korea: Hanwha Corporation, Hanwha Galleria , CMES AI Robotics and more

By | Daily Briefs, South Korea

In today’s briefing:

  • StubWorld: More Partial Offers In The Hanwha Group Complex
  • Examining the Severity of Proration Risk in the Hanwha Galleria Tender Offer
  • CMES AI Robotics IPO Preview


StubWorld: More Partial Offers In The Hanwha Group Complex

By David Blennerhassett

  • After the Kim family-backed Hanwha Energy completed Hanwha Corporation‘s Partial Offer last month, Hanwha Galleria (452260 KS)‘s VP Kim Dong-seon has now launched a Partial Offer for 17.5% in Galleria. 
  • Preceding my comments on Hanwha are the current setup/unwind tables for Asia-Pacific Holdcos.
  • These relationships trade with a minimum liquidity of US$1mn, and a % market capitalisation >20%.

Examining the Severity of Proration Risk in the Hanwha Galleria Tender Offer

By Sanghyun Park

  • The Hanwha Galleria tender offer has no cancellation risk but carries proration risk, keeping the spread at around 7%.
  • For Hanwha Galleria, most floating shares are held by retail investors, and the smaller float size compared to Hansol Logistics further reduces proration risk.
  • Even though the actual trading volume might be a concern, it’s still worth thinking about going for an aggressive strategy to take advantage of the spread, which is around 7%.

CMES AI Robotics IPO Preview

By Douglas Kim

  • CMES AI Robotics is getting ready to complete its IPO on KOSDAQ in October. The expected IPO price is 20,000 won to 24,000 won. 
  • CMES provides intelligent robot solutions that combine artificial intelligence (AI) and three-dimensional (3D) vision technology. CMES’s core technologies include 3D vision sensors and image processing algorithms. 
  • Robotics related IPOs have generated enormous interest in Korea. Although CMES is a small cap name, this robotics related IPO is also likely to garner high interest as well. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief United States: Microsoft Corp, Boston Scientific, Ethereum, KLA-Tencor Corp, Xperi, Packaging Corporation of America, Edwards Lifesciences, Schlumberger Ltd, Clorox Company, American Shared Hospital Servi and more

By | Daily Briefs, United States

In today’s briefing:

  • Microsoft’s Billion Dollar Bets on OpenAI & G42; Azure to Benefit from Industry Growth
  • Boston Scientific Corporation’s Strategic Acquisitions and Portfolio Expansion: A Double-Edged Sword?
  • Crypto Moves #40 – Another ‘DeFi Summer’ Is On the Horizon
  • KLA Corporation: Will The Management’s Continued Focus on High-NA Lithography Yield Results? – Major Drivers
  • XPER: Cash and Cost Savings
  • Packaging Corporation of America: These Are The 5 Most Pivotal Factors Driving Its Performance In 2024 & Beyond! – Financial Forecasts
  • Edwards Lifesciences Corporation: Strategic Acquisitions & Expansion into Heart Failure Management As A Key Growth Catalyst! – Major Drivers
  • Schlumberger Limited: Shift Toward Natural Gas & Offshore Performance Driving Growth! – Major Drivers
  • The Clorox Company: A Dive Into Its Market Positioning
  • AMS: Benefits of Rhode Island, New International JV, Expected ‘Asset-Light’ Model


Microsoft’s Billion Dollar Bets on OpenAI & G42; Azure to Benefit from Industry Growth

By Uttkarsh Kohli

  • Diverse AI Portfolio: Microsoft’s diversified AI investments, including partnerships with G42 and Mistral AI, reduce reliance on OpenAI and ensure continued innovation across multiple AI ventures.
  • Azure’s Competitive Edge: The partnership with OpenAI strengthens Azure’s position by offering exclusive AI-driven cloud services, boosting demand from enterprises seeking advanced automation and productivity tools.
  • Industry Leadership: As AI investment intensifies across the tech sector, Microsoft’s significant spending outpaces peers, positioning the company as a frontrunner while highlighting competitive pressures in the growing AI landscape.

Boston Scientific Corporation’s Strategic Acquisitions and Portfolio Expansion: A Double-Edged Sword?

By Baptista Research

  • Boston Scientific Corporation recently reported its second-quarter results, surpassing expectations with a strong performance driven by its cardiovascular portfolio and robust execution across multiple regions.
  • The company saw a remarkable 16% growth in operational sales, with organic sales climbing 15%, well above its projected range.
  • This growth was bolstered by innovation, clinical evidence, and strategic leadership in various categories.

Crypto Moves #40 – Another ‘DeFi Summer’ Is On the Horizon

By Mads Eberhardt

  • The summer of 2020 marked a pivotal moment for decentralized finance (DeFi), as it gained significant momentum, reflected by the surge in Total Value Locked (TVL) across DeFi protocols.
  • Chart 1: Total Value Locked (TVL) in 2019 and 2020While DeFi continued to grow through 2021, it was the rapid expansion during the summer of 2020 that left a lasting impression on the community, earning the period the moniker ‘DeFi Summer.’Chart 2: Total Value Locked (TVL), All TimeAlthough the actual season may be shifting towards winter, ‘DeFi Summer’ is making a comeback, but the Total Value Locked is still quite far from its 2021 peak.
  • However, it is likely only a matter of time before we surpass that all-time high – potentially as soon as the first half of 2025.

KLA Corporation: Will The Management’s Continued Focus on High-NA Lithography Yield Results? – Major Drivers

By Baptista Research

  • KLA Corporation reported its financial results for the June quarter of 2024, reflecting growth and improvement across several key metrics.
  • Key highlights from the report include revenue, gross margin, and EPS exceeding their respective guidance midpoints.
  • Revenue growth was witnessed both sequentially and year-over-year, indicating a robust market environment that benefits from advanced technology adoption and escalating complexity in semiconductor processes.

XPER: Cash and Cost Savings

By Hamed Khorsand

  • XPER selling Perceive is of greater benefit than the proceeds XPER would immediately receive. 
  • The sale of Perceive to AMZN gives clarity as to the value of the technology XPER has been incubating for many years. 
  • We estimate XPER recognizes approximately $3.5 million to $4 million in quarterly operating losses from Perceive. The cost savings would be material to XPER’s non-GAAP net income.

Packaging Corporation of America: These Are The 5 Most Pivotal Factors Driving Its Performance In 2024 & Beyond! – Financial Forecasts

By Baptista Research

  • Packaging Corporation of America (PCA) reported second-quarter 2024 financial results with both strengths and challenges.
  • The company announced a net income of $199 million, resulting in $2.21 earnings per share (EPS).
  • Excluding special items, the EPS stood at $2.20, showing a slight decrease compared to the same quarter of the previous year at $2.31.

Edwards Lifesciences Corporation: Strategic Acquisitions & Expansion into Heart Failure Management As A Key Growth Catalyst! – Major Drivers

By Baptista Research

  • In reviewing the latest results from Edwards Lifesciences, notable elements of growth and development paired with challenges shed light on the company’s financial and operational trajectory during the second quarter of 2024.
  • With total company sales reaching $1.6 billion, this marked an 8% increase on a constant currency basis compared to the same period last year.
  • While Transcatheter Aortic Valve Replacement (TAVR) growth was not as robust as expected, increasing by 6% globally, the Transcatheter Mitral and Tricuspid Therapies (TMTT) segment demonstrated impressive growth, with a 75% increase in sales.

Schlumberger Limited: Shift Toward Natural Gas & Offshore Performance Driving Growth! – Major Drivers

By Baptista Research

  • In the second quarter of 2024, Schlumberger showcased a strong ability to capitalize on the ongoing growth cycle while driving efficiency throughout its operations.
  • The company reported a 5% increase in revenue compared to the first quarter.
  • Schlumberger’s adjusted EBITDA grew 11%, and its adjusted EBITDA margin expanded 142 basis points.

The Clorox Company: A Dive Into Its Market Positioning

By Baptista Research

  • The Clorox Company presented its fiscal year 2024 fourth-quarter earnings with a moderate sense of optimism and caution, reflecting a period of recovery and strategic realignment.
  • In a context of considerable operational challenges, including a notable cyberattack which the company has recovered from, Clorox has managed to end the fiscal year on a stable note, achieving flat organic sales year-over-year, marked by a robust recovery in subsequent quarters following an 18% decline in the first quarter due to the cyber incident.
  • Baptista Research looks to evaluate the different factors that could influence the company’s price in the near future and attempts to carry out an independent valuation of the company using a Discounted Cash Flow (DCF) methodology.

AMS: Benefits of Rhode Island, New International JV, Expected ‘Asset-Light’ Model

By Zacks Small Cap Research

  • AMS’s Versa HD Linac in Mexico began patient treatments this month, representing a new revenue stream set to begin in 2H24.
  • AMS also recently signed a JV for a Gamma Knife facility in Guadalajara, Mexico, marking its 4th international O&O location.
  • AMS will upgrade an existing Gamma Knife Perfexion system there to an Esprit & also extended another lease agreement with a planned Esprit upgrade.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Indonesia: Bank Rakyat Indonesia and more

By | Daily Briefs, Indonesia

In today’s briefing:

  • Bank Rakyat Indonesia (BBRI IJ) -Stabilizing Before a Rebound


Bank Rakyat Indonesia (BBRI IJ) -Stabilizing Before a Rebound

By Angus Mackintosh

  • Bank Rakyat Indonesia booked flat earnings in 1H2024 despite healthy loan and fee income growth, with a shift towards corporate loans, as it sought to address its problem microloans.
  • The bank front-loaded provisions in 1H2024 but recoveries have seen a steep improvement, with 2H2024 to see lower credit costs. Strong loan corporate loan growth is offsetting slower micro.
  • Bank Rakyat Indonesia remains a unique proxy for micro-lending in Indonesia, with a depositor base of 176m and the skillset to manage risk in this space. Valuations remain attractive. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief India: INOX India Limited, AAC Technologies Holdings and more

By | Daily Briefs, India

In today’s briefing:

  • Inox India Ltd- Forensic Analysis
  • Morning Views Asia: AAC Technologies Holdings, GMR Hyderabad International Airport


Inox India Ltd- Forensic Analysis

By Nitin Mangal

  • INOX India Limited (INOX IN) or IIL is into design, engineering and manufacturing of cryogenic tanks and equipment. These are used in industrial gases, LNG, green hydrogen, metallurgy industries, etc
  • The company came up with its IPO in December 2023 and has posted a decent growth in the last few years.
  • One should however remain cautious about WC trend, receivables provisioning, RPT with promoters, etc.

Morning Views Asia: AAC Technologies Holdings, GMR Hyderabad International Airport

By Leonard Law, CFA

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Japan: Shift Inc, TSE Tokyo Price Index TOPIX and more

By | Daily Briefs, Japan

In today’s briefing:

  • Shift: Is It a Good Time to Buy?
  • Patience Is Often Needed for Small- And Mid-Cap Company Engagements


Shift: Is It a Good Time to Buy?

By Shifara Samsudeen, ACMA, CGMA

  • Shift Inc (3697 JP) s share price has been down 65% YTD as the company’s aggressive investment on HR and system reinforcement led to fall in margins which concerned the market.
  • However, the company has adopted several measures to improve its margins, and we expect the investment in HR and others to generate results going forward.
  • Though share price has moved up slightly, valuation multiples are at a steep discount, and we would look for building a position.

Patience Is Often Needed for Small- And Mid-Cap Company Engagements

By Aki Matsumoto

  • The speed of management reform in Japanese companies is usually slower than investors and shareholders expect. In case of small- to mid-cap stocks, the speed is much slower.
  • In small-to-mid-cap stocks, foreign ownerships are often lower than the average for listed companies, and older companies are often protected by cross-shareholdings. Therefore, engagement should be prepared for sluggish response.
  • The way to resolve this situation is for the company to break the silent shareholder structure or increase shareholders who can exercise their voting rights based on rational decisions.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief China: Xiaomi Corp, AAC Technologies Holdings, Hang Seng Index, Kuaishou Technology and more

By | China, Daily Briefs

In today’s briefing:

  • [Xiaomi Inc. (1810 HK, BUY, TP HK$27) TP Change]: Surprising SU7 Gross Margin a Huge Positive
  • Morning Views Asia: AAC Technologies Holdings, GMR Hyderabad International Airport
  • EQD | HSI May Pull Back, Levels to BUY For Rally Continuation In September
  • [Kuaishou (1024 HK ,BUY, TP HK$75) TP Change]: Temporary Setback from Weak Macro…Reiterate BUY


[Xiaomi Inc. (1810 HK, BUY, TP HK$27) TP Change]: Surprising SU7 Gross Margin a Huge Positive

By Eric Wen

  • Xiaomi reported CY2Q24 revenue, non-IFRS EBIT and non-IFRS net income 5.6%, 32.2%, and 40.0% vs. consensus. 
  • Despite the limited scale and numerous incentives offered at launch, Xiaomi reported an EV gross margin of 15.4%. Greater scale and reduced incentives provide further margin upside in C2H24;
  • Xiaomi’s smartphone and IoT market share gain have accelerated amid the halo-effect stemming from the SU7. We reiterate our BUY rating, and raise  TP to HK$27.0, implying 28.3x CY25 P/E.

Morning Views Asia: AAC Technologies Holdings, GMR Hyderabad International Airport

By Leonard Law, CFA

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


EQD | HSI May Pull Back, Levels to BUY For Rally Continuation In September

By Nico Rosti

  • We have correctly forecasted a August rally for the Hang Seng Index in previous insights, here and then here – the rally is on, but a pullback is coming.
  • The pullback may come in this week or the next, but it’s probably behind the corner, the index can continue higher after the pullback.
  • In this insight we want to expose what are the levels to buy LONG to benefit from a highly probable continuation of the rally in September.

[Kuaishou (1024 HK ,BUY, TP HK$75) TP Change]: Temporary Setback from Weak Macro…Reiterate BUY

By Ying Pan

  • Kuaishou reported C2Q24 revenue, IFRS operating profit, and IFRS net income in-line, in-line, and 5.7% vs.  our estimates; and in-line, 9.0% and 14% vs. the consensus. 
  • The bright spot was strong growth in its advertising and stabilization in the regulation-affected live streaming. Our BUY case of AI empowering mid-sized traffic platforms is intact;
  • We cut TP to HK$75 to reflect the sustained damage of weak consumption. The stock is trading at only 8.5x PE for 2025.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Most Read: Alibaba Group Holding , Seven & I Holdings, China Traditional Chinese Medicine, Hanwha Galleria , Hanwha Corporation, Innovent Biologics Inc, Hanwha Aerospace, Grifols SA and more

By | Daily Briefs, Most Read

In today’s briefing:

  • Alibaba (9988 HK/BABA) Dual Primary Listing: Are We There Yet?
  • Alibaba (9988 HK): Dual Primary Listing & Potential Southbound Flows
  • Couche-Tard Bid for 7&I (3382) – FEFTA and Economic Security
  • TCM (570 HK): Profit Warning Is No Biggie
  • A Tender Offer to Purchase a 17.5% Stake in Hanwha Galleria by Kim Dong-Sun
  • StubWorld: More Partial Offers In The Hanwha Group Complex
  • Innovent Biologics (1801 HK) Adds to Its Oncology Portfolio
  • Both Hanwha Aerospace Spinoffs Remain in KOSPI 200: Trading Value Gap Between Trading Suspension
  • Examining the Severity of Proration Risk in the Hanwha Galleria Tender Offer
  • Brookfield/Grifols: Update & Recap, Spread, Discount


Alibaba (9988 HK/BABA) Dual Primary Listing: Are We There Yet?

By Brian Freitas

  • In its last update, Alibaba Group announced that the company was preparing for its primary listing in Hong Kong and the process was expected to complete by the end August.
  • The Board meets on 14 August to approve results for the three months ending June. Could there be an announcement on the dual primary listing too?
  • Mainland Chinese own between 3.5%-15.5% of companies that converted from Secondary to Dual-Primary in the last few years. Similar buying in Alibaba could take the stock higher from here. 

Alibaba (9988 HK): Dual Primary Listing & Potential Southbound Flows

By Brian Freitas

  • Along with its fiscal 2024 results, Alibaba (9988 HK) announced that they were preparing for their primary listing in Hong Kong and the conversion was expected to complete by August.
  • If the conversion is completed by the end of August, Alibaba (9988 HK) could be added to Southbound Stock Connect in September and that could bring in significant flows.
  • We do not forecast any passive inflows due to the change with Alibaba Group Holding (9988 HK) capped at 8% of the HSI, HSCEI and HSTECH indices.

Couche-Tard Bid for 7&I (3382) – FEFTA and Economic Security

By Travis Lundy

  • The largest potential inbound cross-border M&A in years – for a national champion no less – gets a lot of press coverage. 
  • This morning, a Nikkei article noted Alimentation Couche-Tard (ATD CN) was likely to need “prior approval” from Japanese regulatory authorities for its takeover “the Nikkei has learned.”
  • It wasn’t difficult for the Nikkei to learn that. METI publishes a FEFTA List. 7&i has been on it for years as Type II Designated Business, requiring prior approval.

TCM (570 HK): Profit Warning Is No Biggie

By David Blennerhassett

  • China Traditional Chinese Medicine (570 HK) flagged a 60-70% drop in its 1H24E net profit versus 1H23, due to reduced sales/profit of TCM concentrate, bad debt provisions, and remedial taxes. 
  • MAC triggers? No – Sinopharm won’t exercise such right, even if one was ostensibly triggered. I’d be surprised if Sinopharm wasn’t fully aware of TCM’s underlying operations. 
  • Get involved on any dips today. Trading wide at a 11.7%/38.7% gross/annualised spread, assuming Dec-end payment.

A Tender Offer to Purchase a 17.5% Stake in Hanwha Galleria by Kim Dong-Sun

By Douglas Kim

  • It was announced that a tender offer to purchase a 17.54% stake in Hanwha Galleria has been launched by Kim Dong-Sun (Vice President at Hanwha Galleria).
  • Tender offer price is 1,600 won per share, which is 22.8% higher than the closing price on 22 August. Tender offer amount is 54.4 billion won. 
  • On 23 August, Hanwha Galleria’s share price is likely to rise close to the tender offer price as many investors believe the tender offer is likely to be successful. 

StubWorld: More Partial Offers In The Hanwha Group Complex

By David Blennerhassett

  • After the Kim family-backed Hanwha Energy completed Hanwha Corporation‘s Partial Offer last month, Hanwha Galleria (452260 KS)‘s VP Kim Dong-seon has now launched a Partial Offer for 17.5% in Galleria. 
  • Preceding my comments on Hanwha are the current setup/unwind tables for Asia-Pacific Holdcos.
  • These relationships trade with a minimum liquidity of US$1mn, and a % market capitalisation >20%.

Innovent Biologics (1801 HK) Adds to Its Oncology Portfolio

By Avien Pillay

  • Dupert, a drug for the special treatment of non-small cell cancer has been approved by the NMPA.
  • In 2022, China recorded the highest number of new cancer cases, and their exceptional high incidence of smoking is of particular concern.
  • Innovent’s portfolio of nine oncology drugs is very attractive in the biggest cancer market.

Both Hanwha Aerospace Spinoffs Remain in KOSPI 200: Trading Value Gap Between Trading Suspension

By Sanghyun Park

  • KRX announced that both Hanwha Aerospace and the new Hanwha Industrial Solutions will be added to the KOSPI 200.
  • Since 2020, two K200 spinoffs had both companies remain: DL Holdings and DL E&C in January 2021, and SK Telecom and SK Square in November 2021, with notable value increases.
  • This trade isn’t risk-free and requires a sophisticated hedge setup, but the trading opportunities from this flow situation are worth close attention.

Examining the Severity of Proration Risk in the Hanwha Galleria Tender Offer

By Sanghyun Park

  • The Hanwha Galleria tender offer has no cancellation risk but carries proration risk, keeping the spread at around 7%.
  • For Hanwha Galleria, most floating shares are held by retail investors, and the smaller float size compared to Hansol Logistics further reduces proration risk.
  • Even though the actual trading volume might be a concern, it’s still worth thinking about going for an aggressive strategy to take advantage of the spread, which is around 7%.

Brookfield/Grifols: Update & Recap, Spread, Discount

By Jesus Rodriguez Aguilar

  • Bloomberg reported that Brookfield (BN CN) is seeking bank backing for up to €9.5 billion in debt to facilitate a potential take-private acquisition of Grifols SA (GRF SM).
  • Considering a €10.18/share possible offer price (institutionals are seeking €12), the A shares are trading at a 7.3% gross spread and are pricing a 62.5% possibility of deal completion.
  • The preferreds trading at 17.5% discount vs ordinary shares should be favored in case of takeover, with Long B shares/short A shares my preferred way to get involved.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars